Home Search Abstracts View Session E-mail Abstract Author


Session 22 Oral Abstracts
Recent Developments in Vaccines and Immune-based Therapies
Session Day and Time: Tuesday, 10 am-12:15 pm
Presentation Time: 10:15 am
Room: Room 710


84
Phenotypic Differences in Homing Receptor Expression on SIV-specific CD8+ T Cells Elicited by Intravenous vs Subcutaneous Inoculation with Single-cycle SIV
A Rahmberg1, W Neidermyer1, S Ng1, A Carville1, K Mansfield1, M Piatak2, J Lifson2, P Johnson1, and David Evans*1
1New England Primate Res Ctr, Harvard Med Sch, Southborough, MA, US and 2SAIC, Frederick, MD, US and NCI, Frederick, MD, US

Background:  The gut-associated lymphoid tissues (GALT) represent an important compartment for early virus replication and destruction of CD4+ lymphocytes. Thus, vaccine strategies designed to maximize immunity in mucosal compartments may be more effective at preventing or containing HIV-1 replication at the earliest stages of infection.

Methods:  To determine whether the site of immunization influences the mucosal homing properties of virus-specific T cell responses, separate groups of 8 rhesus macaques were immunized by intravenous vs subcutaneous injection on weeks 0, 8, and 24 with vesicular stomatitis virus (VSV) G trans-complemented single-cycle simian immunodeficiency virus (SIV) (VSV G scSIV). The phenotypic properties of Mamu-A*01-Gag181-189-, Mamu-A*01-Tat28-35-, and Mamu-A*02-Nef159-167-specific CD8+ T cells elicited by each route of immunization were determined by polychromatic flow cytometry using an 8-color tetramer panel that included antibodies to lymphocyte homing and memory markers.

Results:  Significant changes in CCR7 expression were observed as virus-specific CD8+ T cells transitioned from effector to central, and from central to effector, memory phenotypes after each inoculation. While the magnitude of SIV-specific CD8+ T cell responses did not differ significantly for intravenous vs subcutaneous inoculation, the percentages of virus-specific CD8+ T cells that expressed the mucosal homing receptor a4b7 were significantly higher for intravenous than for subcutaneous inoculated animals. Conversely, the percentages of virus-specific CD8+ T cells that expressed E-selectin ligand, a cutaneous homing marker, were significantly higher for subcutaneous than for intravenously inoculated animals. Nevertheless, both routes of immunization resulted in similar SIV-specific T cell frequencies in rectal biopsies.

Conclusions:  Despite inducing polarized homing receptor expression on CD8+ T cells in the peripheral blood, the site of inoculation with VSV G scSIV did not result in detectable differences in the trafficking of virus-specific CD8+ T cells to GALT. These observations suggest that although the site of immunization can influence the profile of homing markers on virus-specific T cells, mucosal trafficking is not an all-or-none phenomenon, and vaccination at peripheral sites can induce cellular immune responses in mucosal compartments.